Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT00759018
What this trial is testing

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

Who this might be right for
Graft vs Host DiseaseGraft-Versus-Host Disease
Mesoblast, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT02204020
What this trial is testing

Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
University of Pittsburgh
Large-scale testing (Phase 3)UnknownNCT02241018
What this trial is testing

MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD

Who this might be right for
Acute Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 200
Testing effectiveness (Phase 2)Study completedNCT00189488
What this trial is testing

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Who this might be right for
Graft Versus Host DiseaseHematologic Malignancies
Swedish Orphan Biovitrum 155
Early research (Phase 1)Study completedNCT01596218
What this trial is testing

Brentuximab Vedotin for Steroid Refractory GvHD

Who this might be right for
Graft vs. Host Disease
Massachusetts General Hospital 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04572815
What this trial is testing

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Who this might be right for
Hematologic and Lymphocytic DisorderHematopoietic and Lymphoid System Neoplasm
Fred Hutchinson Cancer Center 116
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Study completedNCT03270748
What this trial is testing

Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

Who this might be right for
Myeloid Malignancies
Gruppo Italiano Trapianto di Midollo Osseo 78
Not applicableStudy completedNCT03877484
What this trial is testing

Evaluation of the Safety and Effectiveness of ALLEVYN Gentle Border

Who this might be right for
Wound
Smith & Nephew Orthopaedics AG 43
Large-scale testing (Phase 3)Study completedNCT02652130
What this trial is testing

Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD

Who this might be right for
Grade B Acute Graft Versus Host DiseaseGrade C Acute Graft Versus Host DiseaseGrade D Acute Graft Versus Host Disease
Mesoblast, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT03434730
What this trial is testing

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Leukemia+6 more
Memorial Sloan Kettering Cancer Center 46
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Not applicableNot Yet RecruitingNCT07188909
What this trial is testing

Clinical Observation on the Efficacy of Patient-Donor Derived Probiotics in Improving Intestinal Flora Disorder in Patients With Intestinal Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Acute Graft-Versus-Host Disease
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)Looking for participantsNCT06128070
What this trial is testing

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Early research (Phase 1)UnknownNCT05005299
What this trial is testing

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2+3 more
Melbourne Health 18
Not applicableEnded earlyNCT04521777
What this trial is testing

Studying Changes in Physical Function Measures in Stem Cell Transplant Patients at Risk for Steroid Myopathy

Who this might be right for
Acute Graft Versus Host Disease
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Large-scale testing (Phase 3)Looking for participantsNCT05921305
What this trial is testing

Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD

Who this might be right for
Acute Graft Versus Host Disease
Peking University People's Hospital 218
Next Page